BIOLOGY AND THERAPEUTIC TARGETING OF MALIGNANT MONOCYTES IN MYELOID BLOOD CANCERS

$1,721,247FY2021Defense Health AgencyDOD

Brigham & Womens Hospital Inc

Investigators

View source on USAspending →